Assessing High-Risk HPV Infection Rates in Females Undergoing Cervical Cancer Screening in Western India Using HPV-DNA Testing.
Background: As per World Health Organization (WHO), more than 350,000 lives were lost due to cervical cancer in 2022 and around 90% of which were from low- and middle-income countries (LMICs). This shows inequities among accessibility of cervical cancer screening in LMICs. In cervical cancer elimina...
| Published in: | Indian Journal of Community Medicine Vol. 50; no. 6; pp. 933 - 939 |
|---|---|
| Main Authors: | , , , , , , |
| Format: | research tables/charts Journal Article |
| Published: |
Wolters Kluwer India Pvt Ltd
Nov/Dec2025
|
| Online Access: | View this record in EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=189878691&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 189878691 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 09700218 1CQJ jtl: Indian Journal of Community Medicine issn: 09700218 maglogo: N pubinfo: dt: Nov/Dec2025 vid: 50 iid: 6 pid: 16919 pub: Wolters Kluwer India Pvt Ltd artinfo: ui: 189878691 189878691 189878691 10.4103/ijcm.ijcm_190_24 189878691 ppf: 933 ppct: 6 formats: fmt: – @attributes: type: T – @attributes: type: P tig: atl: Assessing High-Risk HPV Infection Rates in Females Undergoing Cervical Cancer Screening in Western India Using HPV-DNA Testing. aug: au: Shah, Anand Kotadia, Bhanuprasad Padmanaban, Ramakrishnan Patel, Rohini Shah, Majal C. Pandya, Shashank Solanki, Nirali affil: Department of Community Oncology, The Gujarat Cancer and Research Institute, Gujarat, India sug: subj: Papillomavirus Infections India Cervix Neoplasms India Cancer Screening India Human Papillomavirus Viruses DNA Analysis Prevalence India Human Female Cross Sectional Studies Data Analysis Software Chi Square Test Confidence Intervals Multivariate Analysis Neoplasms Prevention and Control Cancer Screening Funding Source Adult Middle Age Public Health Adult: 19-44 years Middle Aged: 45-64 years Female ab: Background: As per World Health Organization (WHO), more than 350,000 lives were lost due to cervical cancer in 2022 and around 90% of which were from low- and middle-income countries (LMICs). This shows inequities among accessibility of cervical cancer screening in LMICs. In cervical cancer elimination strategy, WHO has recommended to use high performance test such as human papilloma virus (HPV) DNA test to do cervical cancer screening. Materials and Methods: A cross-sectional study was planned to document the prevalence of high-risk HPV (hrHPV) infection among females undergoing cervical cancer screening. A total of 367 cervical samples were collected at the Gujarat Cancer and Research Institute and community outreach areas of Rajpipla and Dholka talukas of Gujarat State which were tested for hrHPV. Results: Out of 367 samples, 204 samples were collected at cancer hospital and remaining samples were collected from camps. In this study, 31 samples (8.44%) were positive for hrHPV. High parity, early marriage, and irregular menstrual history have shown a significant association for hrHPV infections. Conclusion: Utilization of the HPV DNA test can be scaled up by considering it as the routine screening test which will help us to identify more females with HPV infection and eventually cervical cancer. pubtype: Academic Journal doctype: research tables/charts Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|